SGO on the GO

Hosts Sarah Irish and Nicole Dreibelbis are joined by Megan Lanigan, CRNP, WHNP, AOCNP, and Kimberly Stout, NP, to discuss survivorship care in gynecologic oncology — what survivorship means for patients and providers, the programs and clinics their respective practices have put in place, and practical guidance for APPs looking to build or strengthen survivorship initiatives at their own institutions.

Hosts: Nicole Dreibelbis, CRNP, and Sarah Irish, FNP-BC, AOCNP 
Guests: Megan Lanigan, CRNP, WHNP, AOCNP, and Kimberly Stout, NP

Additional Resources:

• https://www.sgo.org/wp-content/uploads/2026/09/Initiating-a-Survivorship-Program.pptx
• https://www.sgo.org/wp-content/uploads/2026/09/Survivorship-Work-Flow-Chart.docx
• https://www.sgo.org/wp-content/uploads/2026/09/survivorship-survey-central-PA.pdf
• https://www.sgo.org/wp-content/uploads/2026/09/GYN-Survivorship-Program-SOP-4.14.2023.docx
• https://www.sgo.org/wp-content/uploads/2026/09/TREATMENT-SUMMARY-EX.docx
• Survivorship Toolkit | Society of Gynecologic Oncology
• Survivorship | Foundation For Women's Cancer

In this episode of APP Pulse, Julie Justice, CRNP, and Michelle Boisen, MD, join hosts Nicole Dreibelbis and Sarah Irish to discuss Enhanced Recovery After Surgery (ERAS) protocols and their impact on surgical outcomes in gynecologic oncology care. They dig into what ERAS looks like in practice, how it improves patient outcomes, and how APPs can champion implementation at their own institutions. Tune in for practical insights on driving adherence and building better recovery pathways for gynecologic oncology patients. 

Hosts: Nicole Dreibelbis, CRNP, and Sarah Irish, FNP-BC, AOCNP 
Guests: Julie Justice, CRNP, and Michelle Boisen, MD 

Additional Resources:

• Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 update - Gynecologic Oncology 
• ERAS Patient Education: Factsheet and Video
• Webinar: What is ERAS and how can it help us
• Webinar: Implementing ERAS, the nuts and bolts

ADC use is expanding, and APPs play a central role in counseling patients and in identifying and managing toxicities. This episode explores the evolving role of antibody-drug conjugates in gynecologic cancer treatment and highlights current evidence, clinical application and future directions for improving patient outcomes. It provides expert insights into how these target therapies are shaping the landscape of ovarian, endometrial and cervical cancer care. This episode will give APPs plain language they can use with patients, a framework for predicting and managing side effects, and insights on how dose reduction can preserve quality of life while maintaining response.

Hosts: Nicole Dreibelbis, CRNP, WHNP-BC, Sarah Irish, DNP, APRN, FNP-BC
Guest: Jennifer MacDonald, PharmD, BCOP

Suggested Resource: https://www.sciencedirect.com/science/article/pii/S2352578923000103 

Hormone replacement in patients with gynecological cancer has always been a controversial topic. The guests on this episode help to debunk the myths and give guidance on how to have these important conversations and when to offer HRT to our patients.

Hosts: Nicole Dreibelbis, CRNP, WHNP-BC, Sarah Irish, DNP, APRN, FNP-BC
Guests: Jessie Dorne, PA, Rachel Frankenthal, PA-C, MPH, MSCP

Additional Resources:

• https://heatherhirschacademy.com/course/managing-hormone-therapy-for-gynecologic-cancer-survivors/

This episode features recent updates presented at the 2025 European Society for Medical Oncology (ESMO) Congress in Berlin, Germany. Lisa Rauh-Benoit, MD, MPH, and Michelle Boisen, MD discuss data presented for trials including DUO-O, Rina-S/RAINFOL-1 , TV 205 and more, highlighting the key takeaways and implications for practice. 

View the accompanying PDF resource developed by the SGO Education Committee here (https://connected.sgo.org/content/highlights-esmo-2025). 

Stephen Bush, MD, Vice Chair of the SGO Coding and Reimbursement Committee and Kay Moyer, Director of Regulatory Affairs, CRD Associates, discuss changes in Medicare Part B policies and payments and how those impact gynecologic oncologists in 2026. 

Resources:

1. SGO Comments to the Medicare Physician Fee Schedule: SGO-MPFS-PR-2026-_-FINAL.pdf
2. An Update on the CY2026 Medicare Physician Fee Schedule Final Rule | Society of Gynecologic Oncology

Listen to part 3 of the three-part series "Keeping up with the Chemos" focusing on the treatment of Interstitial Lung Disease (ILD). 

Moderator:
Jennifer MacDonald, PharmD, BCOP
 
Speakers: 
Charles Powell, MD, MBA
Paolo Tarantino, MD, PhD
Ira Winer MD, PhD, FACOG

Find the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract). 

Listen to part 2 of the three-part series "Keeping up with the Chemos" focusing on prevention and monitoring of Interstitial Lung Disease (ILD). 

Moderator:
Jennifer MacDonald, PharmD, BCOP
 
Speakers: 
Charles Powell, MD, MBA
Paolo Tarantino, MD, PhD
Ira Winer MD, PhD, FACOG

Find the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract). 

Listen to part 1 of the three-part series "Keeping up with the Chemos" on the therapies associated with Interstitial Lung Disease (ILD). 

Moderator:
Jennifer MacDonald, PharmD, BCOP
 
Speakers: 
Charles Powell, MD, MBA
Paolo Tarantino, MD, PhD
Ira Winer MD, PhD, FACOG

Find the associated clinical practice statement published online in Gynecologic Oncology here (https://www.gynecologiconcology-online.net/article/S0090-8258(25)01007-8/abstract). 

Kaitlin Nicholson, MD and Katherine Tucker, MD, from the SGO Coding and Reimbursement Committee share their expertise in time-based coding to support your billing of inpatient and outpatient visits.  One episode in a continuing series of podcasts on the basics of CPT coding from the SGO. Moderated by David Holtz, MD, Past Chair of the SGO Coding and Reimbursement Committee.